Co-Authors
This is a "connection" page, showing publications co-authored by KAREN RABIN and ERIC SCHAFER.
Connection Strength
0.372
-
Patients with Down syndrome can be included in early phase clinical trials- a report from the T2016-003 Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) study. Leukemia. 2023 05; 37(5):1138-1140.
Score: 0.202
-
Aberrant leukemia-associated immunophenotype as potential harbinger of lineage switch in KMT2A-rearranged leukemia: a case series. Leuk Lymphoma. 2020 12; 61(14):3515-3518.
Score: 0.170